首頁 > 市場調查報告書 > 醫療設備

生技設備

細胞增殖市場規模、佔有率和成長分析（按產品類型、細胞類型、最終用途和地區分類）—產業預測（2026-2033 年）

市場調查報告書

商品編碼

1904174

細胞增殖市場規模、佔有率和成長分析（按產品類型、細胞類型、最終用途和地區分類）—產業預測（2026-2033 年）

Cell Expansion Market Size, Share, and Growth Analysis, By Product (Consumables and Instruments), By Cell Type (Mammalian Cell, Human Stem Cells), By End Use, By Region -Industry Forecast 2026-2033

出版日期: 2025年12月16日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

預計到 2024 年，細胞增殖市場規模將達到 335.3 億美元，到 2025 年將達到 369.8 億美元，到 2033 年將達到 810.2 億美元，預測期（2026-2033 年）的複合年成長率為 10.3%。

細胞擴增市場的主要驅動力在於能夠提高細胞、基因和生物療法開發效率的解決方案的進步，這些方案在降低人力成本的同時，也能提供可靠的結果。主要市場參與企業正在擴展其產品線，以滿足全球對這些治療方法日益成長的需求。一次性使用系統 (SUS) 的應用正在革新細胞療法的生產方式，它最大限度地降低了交叉污染風險，提高了細胞密度，同時降低了長期成本。來自私部門和政府部門的投資增加，以及推廣細胞療法的舉措，都在推動市場成長。此外，為確保產品品質而轉向無血清培養基的趨勢正在加速發展，這進一步鞏固了細胞療法在生命科學領域的重要性，並推動了市場擴張。

細胞增殖市場促進因素

細胞增殖技術在生物製藥研發中的應用日益廣泛，是推動市場成長的關鍵因素。包括單株抗體、疫苗和細胞療法在內的生物製藥產品，都依賴複雜且可擴展的細胞增殖過程。隨著慢性病發病率的上升和全球對個人化醫療需求的日益成長，對高品質生物製藥的需求也隨之增加。對創新治療方法的日益關注，推動了對先進細胞增殖技術的投資，進而促進了技術進步和生產效率的提升。這一趨勢不僅有助於開發有效的治療方法，也促進了整個細胞增殖市場的擴張。

限制細胞增殖市場的因素

影響細胞擴增市場的關鍵限制因素之一是與細胞治療技術相關的各種監管和倫理挑戰。細胞產品的開發和商業化過程需要遵守嚴格的監管標準，而這些標準在不同地區可能有顯著差異。此外，圍繞胚胎幹細胞的使用和基因編輯技術的應用所引發的倫理困境也帶來了進一步的挑戰，並可能阻礙研發工作。這些因素共同構成了一個複雜的局面，有可能減緩該領域的進展和創新，因此，相關人員必須有效應對這些障礙。

細胞增殖市場趨勢

受對更精確、更符合生理實際的細胞環境的需求驅動，細胞培養市場正經歷著向創新3D細胞培養和反應器技術的重大轉變。這種從傳統2D培養系統的轉變顯著提高了細胞功能、活力和可重複性，使其成為再生醫學、腫瘤學和藥物研發領域的關鍵工具。隨著研究人員和臨床醫生逐漸認知到傳統方法的局限性，對先進培養技術的投資正在激增，以支持建立更具預測性的人體生理模型。這一趨勢反映了對能夠簡化藥物研發流程並改善治療效果的高度精密系統日益成長的需求。

前五大公司對比
主要企業的市場定位（2025 年）
主要市場參與者所採取的策略
近期市場趨勢
公司市佔率分析（2025 年）
主要企業公司簡介
- 公司詳情
- 產品系列分析
- 依業務板塊進行公司股票分析
- 2023-2025年營收年比比較
主要企業簡介
- 賽默飛世爾科技（美國）
- 貝克頓·迪金森公司（美國）
- 龍沙集團（瑞士）
- 康寧公司（美國）
- 默克集團（德國）
- Sartorius Stedim BIoTech SA（德國）
- 泰爾茂株式會社（日本）
- Miltenyi BIoTec GmbH（德國）
- 丹納赫公司（美國）
- 幹細胞技術公司（加拿大）
- 貝克曼庫爾特公司（美國）
- Takara Bio Inc.（日本）
- RepliCel 生命科學（加拿大）
- NexImmune公司（美國）
- Celltainer BIoTech BV（荷蘭）
- Repligen公司（美國）
- Getinge AB（瑞典）
- Bio-Techne公司（美國）
- PromoCell GmbH（德國）
- Himedia Laboratories（印度）

結論與建議

簡介目錄

Product Code: SQMIG35J2071

Cell Expansion Market size was valued at USD 33.53 Billion in 2024 and is poised to grow from USD 36.98 Billion in 2025 to USD 81.02 Billion by 2033, growing at a CAGR of 10.3% during the forecast period (2026-2033).

The market for cell expansion is significantly driven by advancements in solutions that enhance efficiency in cell therapy, gene therapy, and biological therapy development, reducing manpower and costs while delivering reliable results. Key market players are broadening their product offerings to address the surging global demand for these therapies. The adoption of single-use systems (SUS) is revolutionizing cell therapy production by minimizing cross-contamination risks and enhancing cell density while lowering long-term costs. Increased investments from both private and government sectors, along with initiatives promoting cellular therapies, are propelling market growth. Additionally, the push for serum-free media to ensure product quality is gaining traction, further solidifying the prominence of cellular therapies in the life sciences arena and driving market expansion.

Top-down and bottom-up approaches were used to estimate and validate the size of the Cell Expansion market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Cell Expansion Market Segments Analysis

Global Cell Expansion Market is segmented by Product, Cell Type, Application, End Use and region. Based on Product, the market is segmented into Consumables, Culture Flasks and Accessories and Instruments. Based on Cell Type, the market is segmented into Mammalian, Microbial and Others. Based on Application, the market is segmented intobiopharmaceuticals, Tissue Culture & Engineering, Vaccine Production, Drug Development, Gene Therapy, Cancer Research, Stem Cell Research and Others. Based on End Use, the market is segmented into Biopharmaceutical & Biotechnology Companies, Research Institutes, Cell Banks and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Cell Expansion Market

The growing application of cell expansion techniques in biopharmaceutical development serves as a significant catalyst for market growth. Biopharmaceuticals, including monoclonal antibodies, vaccines, and cell-based therapies, depend on intricate and scalable cell expansion processes. As chronic diseases become more prevalent and the demand for personalized medicine rises globally, there is an increasing necessity for high-quality biopharmaceutical products. This heightened focus on innovative therapies drives investments in advanced cell expansion technologies, fostering advancements and enhancing production efficiency. Consequently, this trend not only supports the development of effective treatments but also contributes to the overall expansion of the cell expansion market.

Restraints in the Cell Expansion Market

One significant constraint impacting the cell expansion market is the array of regulatory and ethical challenges associated with cell-based therapeutic technologies. The process of developing and marketing cell-based products necessitates adherence to stringent regulatory standards, which can differ dramatically between various regions. Additionally, ethical dilemmas surrounding the utilization of embryonic stem cells and the application of gene editing techniques pose further difficulties, potentially stifling research and development efforts. These factors combine to create a complex landscape that can slow progress and innovation within the sector, making it essential for stakeholders to navigate these obstacles effectively.

Market Trends of the Cell Expansion Market

The Cell Expansion market is witnessing a significant shift towards innovative 3D cell culture and bioreactor technologies, driven by the need for more accurate and physiologically relevant cellular environments. This transition from traditional 2D culture systems enhances cell function, survival, and reproducibility, making it a vital asset in regenerative medicine, oncology, and drug discovery. As researchers and clinicians recognize the limitations of conventional methods, investments in advanced culture techniques are surging to support more predictive models of human physiology. This trend reflects the broader demand for high-fidelity systems that can streamline the drug development process and improve therapeutic outcomes.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis

Global Cell Expansion Market Size by Product & CAGR (2026-2033)

Market Overview
Consumables
- Reagents, Media, & Serum
- Other Consumables
Culture Flasks and Accessories
- Tissue Culture Flasks
- Bioreactor Accessories
- Other Culture Flasks and Accessories
Instruments
- Automated Cell Expansion Systems
- Cell Counters
- Centrifuges
- Bioreactors
- Other Instruments

Global Cell Expansion Market Size by Cell Type & CAGR (2026-2033)

Market Overview
Mammalian
- Human
- Stem Cells (SCs)
- Adult SCs
- Embryonic SCs
- Induced Pluripotent SCs
- Differentiated Cells
- Animal
Microbial
Others

Global Cell Expansion Market Size by Application & CAGR (2026-2033)

Market Overview
Biopharmaceuticals
Tissue Culture & Engineering
Vaccine Production
Drug Development
Gene Therapy
Cancer Research
Stem Cell Research
Others

Global Cell Expansion Market Size by End Use & CAGR (2026-2033)

Market Overview
Biopharmaceutical & Biotechnology Companies
Research Institutes
Cell Banks
Others

Global Cell Expansion Market Size & CAGR (2026-2033)

North America (Product, Cell Type, Application, End Use)
- US
- Canada
Europe (Product, Cell Type, Application, End Use)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Product, Cell Type, Application, End Use)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Product, Cell Type, Application, End Use)
- Brazil
- Rest of Latin America
Middle East & Africa (Product, Cell Type, Application, End Use)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

Thermo Fisher Scientific (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Becton, Dickinson and Company (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Lonza Group (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Corning Incorporated (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck KGaA (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sartorius Stedim Biotech SA (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Terumo Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Miltenyi Biotec GmbH (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Danaher Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Stemcell Technologies Inc. (Canada)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Beckman Coulter Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Takara Bio Inc. (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
RepliCel Life Sciences (Canada)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
NexImmune Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Celltainer Biotech BV (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Repligen Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Getinge AB (Sweden)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Techne Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PromoCell GmbH (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Himedia Laboratories (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments